Clinical studies have linked variations in plasma NPY and polymorphisms in genes for NPY and its receptors with PTSD (307), making this system an attractive pharmacotherapeutic target for stress-related disorders (306). The gene discussed is NPY; the disease is post-traumatic stress disorder.